Cargando…

Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation

BACKGROUND: Some patients with atrial fibrillation (AF) received underdoses of non-vitamin K antagonist oral anticoagulants (NOACs) in the real world. Underdosing is defined as administration of a dose lower than the manufacturer recommended dose. OBJECTIVES: To identify the efficacy and safety of u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamaji, Hirosuke, Murakami, Takashi, Hina, Kazuyoshi, Higashiya, Shunichi, Kawamura, Hiroshi, Murakami, Masaaki, Kamikawa, Shigeshi, Komatsubara, Issei, Kusachi, Shozo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Cardiovascular Pharmacology 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295475/ https://www.ncbi.nlm.nih.gov/pubmed/28170360 http://dx.doi.org/10.1097/FJC.0000000000000448

Ejemplares similares

Adjunctive interpulmonary isthmus ablation has no added effects on atrial fibrillation recurrence
por: Higashiya, Shunichi, et al.
Publicado: (2017)

Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
por: Yamaji, Hirosuke, et al.
Publicado: (2016)

Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes
por: Yamaji, Hirosuke, et al.
Publicado: (2019)

Correlation of the peak oxygen consumption and ventilatory aerobic threshold by cardiopulmonary exercise testing with atrial fibrillation recurrences after ablation in patients with paroxysmal atrial fibrillation
por: Yamashita, Daiki, et al.
Publicado: (2020)

Reproducibility of cardiopulmonary exercise testing between one after and 1–3 weeks after elective percutaneous coronary intervention
por: Tanaka, Ryou, et al.
Publicado: (2023)

Off-Label Underdosing or Overdosing of Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis
por: Wu, Xiaojuan, et al.
Publicado: (2021)

Detection of overdose and underdose prescriptions—An unsupervised machine learning approach
por: Nagata, Kenichiro, et al.
Publicado: (2021)

Persistent Underdosing of Benzodiazepines for Status Epilepticus: The Weight Is the Hardest Part
por: Noe, Katherine
Publicado: (2021)

Explicit underdose control based on toxicity: Four points to consider
por: Frankel, Paul H., et al.
Publicado: (2022)

High frequency of valganciclovir underdosing for cytomegalovirus prophylaxis after renal transplantation
por: Rissling, Olesja, et al.
Publicado: (2018)

Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?
por: Sorli, Luisa, et al.
Publicado: (2019)

Modelling bodyweight to avoid anthelmintic underdosing of goats in resources-limited settings
por: Evans, M. J., et al.
Publicado: (2023)

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients?
por: Ayerbe, Luis, et al.
Publicado: (2021)

Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial Findings
por: Arashi, Hiroyuki, et al.
Publicado: (2022)

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis
por: Santarpia, Giuseppe, et al.
Publicado: (2015)

Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE‐CIRCUIT trial
por: Yoshida, Yukihiko, et al.
Publicado: (2018)

Uninterrupted Direct Oral Anticoagulants Without a Change in Regimen for Catheter Ablation for Atrial Fibrillation Is an Acceptable Protocol
por: Oshima, Tsukasa, et al.
Publicado: (2021)

Factors influencing adherence to non-vitamin K antagonist oral anticoagulants in the early period after atrial fibrillation catheter ablation in China
por: Hu, Zhi-Cheng, et al.
Publicado: (2020)

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? – Authors' reply
por: Rentsch, Christopher T, et al.
Publicado: (2021)

Clostridium Histolyticum Collagenase Underdosed for Multicord Injection in Dupuytren’s Disease: A Retrospective Cohort Study
por: Boriani, Filippo, et al.
Publicado: (2022)

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
por: Murakawa, Yuji, et al.
Publicado: (2017)

Oral Anticoagulation Discontinuation Following Catheter Ablation of Typical Atrial Flutter
por: Alqam, Bilal M., et al.
Publicado: (2021)

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
por: Gjermeni, Diona, et al.
Publicado: (2023)

Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants
por: Brinkmeier-Theofanopoulou, Maria, et al.
Publicado: (2018)

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2015)

Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis
por: Vamos, Mate, et al.
Publicado: (2016)

Meta-analysis of controlled studies on minimally interrupted vs. continuous use of non-vitamin K antagonist oral anticoagulants in catheter ablation for atrial fibrillation
por: van Vugt, Stijn P G, et al.
Publicado: (2021)

Coronary Pressure Measurement Based Decision Making for Percutaneous Coronary Intervention
por: Iwasaki, Kohichiro, et al.
Publicado: (2009)

Hospital admission profile related to poisoning by, adverse effect of and underdosing of psychotropic drugs in England and Wales: An ecological study
por: Al-Daghastani, Tamara, et al.
Publicado: (2022)

Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment
por: Zhang, Rong-feng, et al.
Publicado: (2021)

Pulsed Field Ablation of the Porcine Ventricle Using a Focal Lattice-Tip Catheter
por: Kawamura, Iwanari, et al.
Publicado: (2022)

Utilization of Anticoagulants in Nonvalvular Atrial Fibrillation Before and After Catheter Ablation at Shanghai, China
por: Tingting, Chen, et al.
Publicado: (2019)

A case of successful radiofrequency catheter ablation for atrial tachycardia originating from the inferior vena cava using high-resolution mapping
por: Fukumoto, Yusaku, et al.
Publicado: (2022)

Activated Clotting Time Monitoring during Atrial Fibrillation Catheter Ablation: Does the Anticoagulant Matter?
por: Martin, Anne-Céline, et al.
Publicado: (2020)

Comparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants
por: Heo, MuHyung, et al.
Publicado: (2023)

Uninterrupted or Minimally Interrupted Direct Oral Anticoagulant Therapy is a Safe Alternative to Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Meta-Analysis
por: Ottóffy, Máté, et al.
Publicado: (2020)

Comparison between cryoballoon ablation and radiofrequency catheter ablation for atrial fibrillation in patients on hemodialysis
por: Hayashi, Takahiro, et al.
Publicado: (2021)

Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin
por: Shin, Dong Geum, et al.
Publicado: (2016)

Figure-of-eight suture for venous hemostasis in fully anticoagulated patients after atrial fibrillation catheter ablation
por: Lakshmanadoss, Umashankar, et al.
Publicado: (2017)

Safety and Efficacy of Uninterrupted Oral Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation with Different Techniques
por: Schiavone, Marco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3a3qno5hdm7lqukchtfhhr67ib